Operator: Good morning and thank you for standing by, and welcome to the Better Therapeutics First Quarter 2023 Conference Call. At this time all participants are in a listen-only mode.
Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) – Research analysts at Chardan Capital boosted their FY2023 earnings per share estimates for shares of Pear Therapeutics in a report issued on Monday, April 3rd. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($0.56) for the year, up from […]
Accelera Innovations (OTCMKTS:ACNV – Get Rating) and Pear Therapeutics (NASDAQ:PEAR – Get Rating) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation. Earnings & Valuation This table compares Accelera Innovations […]